Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2021 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Progressive Multifocal Leukoencephalopathy in Relapsed Ph+ Acute Lymphoblastic Leukemia after Cord Blood Transplantation and Blinatumomab Treatment: A Case Report and Literature Review.
Edahiro T, Fukushima N, Otani T, Nakamori M, Nakamichi K, Chishaki R, Fujino K, Mino T, Yoshida T, Sugihara S, Nishizawa M, Ichinohe T. Edahiro T, et al. Among authors: fujino k. Acta Haematol. 2022;145(6):655-661. doi: 10.1159/000526132. Epub 2022 Jul 27. Acta Haematol. 2022. PMID: 35896078 Review.
Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis.
Edahiro T, Kawase T, Nagoshi H, Fujino K, Toishigawa K, Miyama T, Mino T, Yoshida T, Morioka T, Hirata Y, Noma M, Fujii T, Nishizawa M, Fukushima N, Ichinohe T. Edahiro T, et al. Among authors: fujino k. Hematology. 2021 Dec;26(1):186-198. doi: 10.1080/16078454.2021.1881228. Hematology. 2021. PMID: 33594942
Successful combination treatment with azacitidine and venetoclax as a bridging therapy for third allogenic stem cell transplantation in a patient with 11q23/MLL-rearranged complex karyotype acute myeloid leukemia.
Edahiro T, Ureshino H, Chishaki R, Fujino K, Mino T, Yoshida T, Fukushima N, Ichinohe T. Edahiro T, et al. Among authors: fujino k. EJHaem. 2022 Dec 26;4(1):273-275. doi: 10.1002/jha2.630. eCollection 2023 Feb. EJHaem. 2022. PMID: 36819153 Free PMC article.
Successful Pre- and Post-transplant Administration of Gilteritinib in a Patient with Relapsed and Refractory Acute Myeloid Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation.
Edahiro T, Ureshino H, Chishaki R, Fujino K, Mino T, Yoshida T, Fukushima N, Ichinohe T. Edahiro T, et al. Among authors: fujino k. Intern Med. 2023 Aug 1;62(15):2243-2247. doi: 10.2169/internalmedicine.1069-22. Epub 2022 Nov 30. Intern Med. 2023. PMID: 36450475 Free PMC article.